Bioactivity:

Giredestrant potently competes with estradiol for binding and induces a conformational change within the ER ligand binding domain.�Giredestrant has anti-tumor activity.�Giredestrant, a non-steroidal ER ligand, is an orally active and selective estrogen re

CAS nr:

1953133-47-5

Purity:

98%

Molecular Weight:

522,55

SMILES:

C[C@H](Cc1c2[nH]c3c1cccc3)N(CC(CO)(F)F)[C@@H]2c(c(F)cc(NC1CN(CCCF)C1)c1)c1F

Formula:

C27H31F5N4O

Pathway:

Endocrinology/Hormones,Endocrinology/Hormones

Target:

Estrogen Receptor/ERR,Estrogen/progestogen Receptor